AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tacrosoft 0.03% Gel

Prescription Icon
Prescription Required

Marketer

Oziel Pharmaceuticals Pvt Ltd

Salt Composition

Tacrolimus (0.03% w/w)

Overview Tacrosoft 0.03% Gel

Eczema (atopic dermatitis) is treated with Tacrosoft 0.03% Gel, which reduces inflammation (skin redness and swelling) by modulating specific immune cell activity. This alleviates itching and improves atopic dermatitis rashes. Apply Tacrosoft 0.03% Gel externally, two to four times daily to affected areas, or as directed by your physician. Gently and evenly distribute the gel, rubbing it in completely. Avoid overuse and do not bandage or cover treated skin. Consult your doctor if no improvement is seen after two weeks, or if your condition worsens. Common side effects may include redness, headache, folliculitis, and application site reactions such as burning, irritation, itching, and redness. Use during pregnancy or breastfeeding is generally avoided unless medically necessary.

Uses of Tacrosoft 0.03% Gel

Managing atopic dermatitis

Major Benefits of Tacrosoft 0.03% Gel:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application guidelines. Before applying the gel, cleanse and thoroughly dry the affected skin. Wash your hands afterward, except when the affected area is on your hands.

Common Side effects of Tacrosoft 0.03% Gel:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Tacrosoft 0.03% Gel:

Apply this medication only to the skin's surface. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application guidelines. Before applying the gel, ensure the affected area is clean and dry. Afterwards, wash your hands thoroughly, except when the affected area is on your hands.

How Tacrosoft 0.03% Gel works:

Immunosuppressant Tacrosoft 0.03% Gel reduces skin inflammation—the redness and swelling—by inhibiting the action of specific immune cells. This alleviates itching and improves the rash associated with atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tacrosoft 0.03% Gel during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The application of Tacrosoft 0.03% Gel while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No drug interactions identified.

What if you forget to take Tacrosoft 0.03% Gel :

Should you forget a dose of Tacrosoft 0.03% Gel, apply it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen.

Facts to Know About Tacrosoft 0.03% Gel

LabelValue
Chemical Classification Macrolide Antibiotics
Developing Habits No.
Type of Treatment Cancer Medications
Actions Calcineurin inhibitor immunosuppressants

FAQs on Tacrosoft 0.03% Gel

Tacrosoft 0.03% Gel is an immunomodulatory medicine that primarily reduces immune system activity. It treats moderate to severe eczema (atopic dermatitis) in adults whose condition is unresponsive to steroids or who experience steroid side effects. By modulating the overactive immune response responsible for the inflammation, itchiness, redness, and dryness characteristic of atopic dermatitis, Tacrosoft 0.03% Gel alleviates these symptoms.
Applying Tacrosoft 0.03% Gel topically may cause mild to moderate skin irritation, including burning, itching, redness, warmth, pain, altered sensation, and rash. These typically resolve within a week. Treatment may also increase the risk of inflamed or infected hair follicles, cold sores, acne, and generalized herpes simplex infections.
Tacrosoft 0.03% Gel offers safe and effective short-term treatment of atopic dermatitis, demonstrating superior safety compared to other immunosuppressants. Minimal systemic absorption following topical application results in fewer side effects than oral immunosuppressants.
Tacrosoft 0.03% Gel is not a controlled substance because it lacks abuse potential. Controlled substances require authorization from both a doctor and regulatory authorities due to their potential for misuse.
Studies show a potential link between prolonged use of Tacrosoft 0.03% Gel and an increased lymphoma (lymph node tumor) risk. A small number of patients using Tacrosoft 0.03% Gel or similar medications have developed skin cancer or lymphoma. If using Tacrosoft 0.03% Gel for over six weeks, or if your eczema worsens or fails to improve, consult your doctor.
Tacrosoft 0.03% Gel is a non-steroidal medication that modulates the immune system. It treats eczema, particularly atopic dermatitis, without the skin thinning or other side effects associated with steroids.
Tacrosoft 0.03% Gel
119
MRP 145
17% off